Back to 
MOORE CAPITAL MANAGEMENT, LP
MOORE CAPITAL MANAGEMENT, LP
PTGX
Showing 0 of 2 quarters
Position history for MOORE CAPITAL MANAGEMENT, LP's holdings in PROTAGONIST THERAPEUTICS INC
No. Moore Capital Management exited its PTGX (Protagonist Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 22,580 shares worth $623,660. Moore Capital Management first reported PTGX in Q2 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.